pd-y-64
Pen Injection Applications
Pen injectors are widely used for diabetes, obesity, growth hormone, and fertility treatments because they enable convenient, precise self-administration of subcutaneous hormones like insulin, GLP-1 agonists, somatropin, and gonadotropins through user-friendly pen designs. Pen injectors can simplify dosing and reduce preparation errors, promoting greater adherence for chronic daily injection regimens in diabetes and growth hormone therapy or time-sensitive cycles in fertility and obesity management. Terumo Medical Care Solutions – Pharmaceutical offers Nanopass™ Needles which are intended for injection by pen devices.
text-vertical-top
image-media-type
TBD
true
media-right
true
true
tab1
Description
tab2
Fertility
tab3
Growth Hormones
tab4
Obesity
tab5
Diabetes
tab6
Related Products
tab8
Advantages
pd-y-64
Fertility Pen Injector Needle
Pen Injection for Fertility
Terumo Pharmaceutical Solutions Nanopass™ Needles are designed for the subcutaneous (SC) administration of approved drug products when integrated into pen injector systems.
grid-texts-60
text-vertical-center
image-media-type
TBD
media-left
true
pd-y-16
Needles for Fertility Pen Injectors
- This product is intended for use with a pen injector device for patients who require the subcutaneous (SC) injection of drugs including insulin as a therapy.
- Business cases confirm the suitability of Nanopass™ Needles for self-injection kits intended to trigger fertility status changes.
normal
pd-y-64
Growth Hormone Pen Injector Needle
Pen Injection for Growth Hormone
Human Growth Hormone (hGH or somatropin) are a specific type of growth hormone produced by the human body that regulate growth, cell repair, and metabolism. Terumo Pharmaceutical Solutions’ Nanopass™ Needles are compatible with major pen injector devices.
grid-texts-60
text-vertical-center
image-media-type
TBD
media-right
true
pd-y-16
Needles for Growth Hormone Pen Injectors
- Compatibility – Proven track record for the successful use in injection growth hormones by pen injector devices.
- Business cases confirm the suitability of Nanopass™ Needles for self-injection kits intended to cure growth deficits.
- This product is intended for use with a pen injector device for patients who require the subcutaneous (SC) injection of drugs including growth hormone as a therapy.
normal
pd-y-64
Obesity Pen Injector Needle
Pen Injection for Obesity
Terumo Pharmaceutical Solutions offers Nanopass™ Needles that can be used in pen injectors to allow self-administration for the treatment of chronic diseases such as obesity.
grid-texts-60
text-vertical-center
image-media-type
TBD
media-left
true
pd-y-16
Needles for Obesity Pen Injectors
- Compatibility with EN ISO 11608-2
- Needle specification range established to cover a broad patient cohort
normal
pd-y-64
Diabetes Pen Injector Needle
Pen Injection for Diabetes
Terumo Pharmaceutical Solutions Nanopass™ Needles offer confirmed compatibility with major pen injector designs. Many diabetes patients use pen injectors for daily subcutaneous (SC) injections of insulin or other diabetes drug treatments.
grid-texts-60
text-vertical-center
image-media-type
TBD
media-right
true
pd-y-32
pd-y-16
Needles for Diabetes Pen Injectors
- Needle Design – Reduced diameter thin-wall needle with unique asymmetric lancet bevel.
normal
pd-y-64
Related Products
Terumo Injector Pen Needle Products
media-top
true
variation-1
cards-3
white-bg
true
variation-1-card
image
TBD
Nanopass™ 32.5G Needle
Injection Needles
The Nanopass™ 32.5G Needle is intended for use with a pen injector device for the subcutaneous injection of drugs, including insulin and human growth hormone. Offered in three different lengths, the Nanopass™ 32.5G Needle allows Healthcare Professionals (HCPs) to choose the most suitable pen needle for a specific patient cohort.
View Product
View Product
link
variation-1-card
image
Nanopass™ 34G Needle
The Nanopass™ 34G is the world's thinnest double-tapered 34G pen needle1, redefining patient comfort for self-injections. Designed for the subcutaneous (SC) injection of therapeutics, including insulin and human growth hormones (HGH), Nanopass™ 34G offers the quality and supply reliability needed to meet drug developers’ toughest parenteral delivery challenges and product commercialization goals.
View Product
View Product
link
pd-y-64
pd-y-64
Advantages
Global Capabilities for Pen-Injections
Partnering with Terumo Pharmaceutical Solutions on your next pen injector product provides you with access to integrated injection device design, advanced product development expertise, and globally scaled syringe and needle manufacturing that meets ISO 13485 quality management standards. Our mission of “contributing to society through healthcare” guides us in delivering high‑quality parenteral drug delivery products and services to both customers and patients.
button psd-primary
text-vertical-center
image-media-type
TBD
media-left
true
pd-y-64
pd-y-64
Contact
Connect with Our Pen Injection Experts Today
Pharmaceutical and biotechnology companies partner with Terumo Pharmaceutical Solutions to bring their medical innovations to life. If you have any questions about how we can help you to develop or manufacture your next pen injector or autoinjector product, reach out to us today.
Contact Us
Contact Us
button psd-primary
text-vertical-center
image-media-type
TBD
media-right
true
pd-y-64